James P. Garnett
Papers
1
Total Citations
66
H-Index
1
About
James P. Garnett is a leading figure in respiratory biology and drug discovery, renowned for his pioneering work in developing advanced in vitro models of the human airway. His primary research focuses on creating miniaturized, high-throughput systems that faithfully replicate the human small airway epithelium, addressing a critical bottleneck in respiratory medicine: the limited availability of primary airway cells for research. Garnett’s major contribution is the development of a groundbreaking 96-Transwell air–liquid interface (ALI) human small airway epithelial model, published in 2020 and cited over 66 times. This innovation miniaturizes traditional ALI cultures into a microplate format, enabling scalable, physiologically relevant testing of drug candidates, toxicants, and disease mechanisms while conserving precious clinical samples. By overcoming the challenges of cell scarcity and limited ex vivo proliferation, his work has accelerated preclinical respiratory drug discovery and reduced reliance on animal models. Garnett’s achievements have positioned him as a key innovator in organ-on-a-chip and 3D culture technologies, with his platform widely adopted for studying conditions like asthma, COPD, and cystic fibrosis. His contributions continue to empower researchers worldwide to explore respiratory biology with unprecedented efficiency and translational relevance.
Research Focus
Key Achievements
Top Papers
- 1